JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2016, Vol. 54 ›› Issue (2): 68-74.doi: 10.6040/j.issn.1671-7554.0.2015.081

Previous Articles     Next Articles

Effects of P38 mitogen-activated protein kinase signal pathway on the expression of urokinase-type plasminogen activator in ovarian cancer

ZHANG Chunxia1, ZOU Cunhua1, SONG Dongdong2, YU Jiang1   

  1. 1. Department of Genaecology and Obstetrics;
    2. Department of General Surgery, Shengli Oil Field Central Hospital, Dongying 257000, Shandong, China
  • Received:2015-01-21 Online:2016-02-10 Published:2016-02-10

PDF (PC)

161

Abstract: Objective To explore the effects of P38 mitogen-activated protein kinase(P38MAPK)signal pathway on the expression of urokinase-type plasminogen activator(uPA)in ovarian cancer. Methods The expressions of uPA, P38MAPK, extracellular regulated kinase(ERK), and AKT/kinase B in 49 cases of ovarian cancer were detected with immunohistochemistry. The expressions of uPA and P38MAPK in ovarian cancer cell line HO-8910 and HO-8910PM were detected with Western blotting. Changes of uPA were observed after P38MAPK, ERK and AKT signal pathway were blocked by SB203580, U0126 and MK-2206 respectively. Results The results of immunohistochemistry showed that positive expression rates of uPA, P38MAPK, ERK and AKT were 61.22%, 57.14%, 53.06%, and 55.10%, respectively. The expression of the uPA was related to clinicopathologic stage, differentiation and metastasis(P<0.05), and positively correlated with P38MAPK(P=0.01), but not related to ERK or AKT(P>0.05). The expressions of AKT and ERK were related to lymph node metastasis and greater omentum metastasis(P<0.05). The expression of uPA and P38MAPK in HO-8910PM was higher than those in HO-8910, and it reduced when the P38MAPK signal pathway was blocked by SB203580. But it had no significant change after dealing with U0126 and MK-2206 respectively. The postoperative survival rate was negatively correlated with P38MAPK and uPA. Conclusion The 山 东 大 学 学 报 (医 学 版)54卷2期 -张春霞,等.P38MAPK信号通路对卵巢癌中尿激酶型纤维蛋白酶原激活剂的影响 \=-P38MAPK signal pathway are activated in ovarian cancer and it can upregulate the expression of uPA, but ERK and AKT signal pathway are not involved in the regulation of uPA expression, which indicates that P38MAPK and uPA may play an important role in the invasion, metastasis and prognosis assessment of ovarian cancer.

Key words: Ovarian tumor, Urokinase-type plasminogen activator, P38MAPK signal pathway, Extracellular regulated protein kinases, Protein kinase B

CLC Number: 

  • R737.31
[1] 吕树卿, 尉蔚, 张灿灿, 等. HGF/PARP-1信号通路调控卵巢癌细胞侵袭转移的作用[J]. 山东大学学报(医学版), 2015, 53(7): 1-7. LÜ Shuqing, WEI Wei, ZHANG Cancan, et al. The mechanism of HGF/PARP-1 signaling pathway regulating invasion and metastasis of ovarian cancer[J]. Journal of Shandong University(Health Sciences), 2015, 53(7): 1-7.
[2] 崔婷婷, 席淑华. MAPK信号转导通路与肿瘤的发生[J].实用肿瘤杂志, 2013, 28(5): 550-552. CIU Tingting, XI Shuhua. MAPK signal pathways and tumor[J]. Journal of Practical Oncology, 2013, 28(5): 550-552.
[3] 廖明娟, 陈红风. PI3K/Akt/mTOR信号通路抑制剂在乳腺癌中的研究进展[J]. 中华肿瘤防治杂志, 2012,19(3): 230-234. LIAO Mingjuan, CHEN Hongfeng. Targeted therapy on PI3K/Akt/Mtor signaling pathway in breast cancer[J]. Chinese Journal of Cancer Prevention and Treatment, 2012, 19(3): 230-234.
[4] 陈佰清, 叶锋, 马恒年, 等. 女性结肠癌患者癌组织中ER和uPA蛋白的表达及其临床意义[J]. 中国妇幼保健, 2014, 1: 141-143. CHEN Baiqing, YE Feng, MA Hengnian, et al. Expressions and its clinical significance of ER and uPA protein in the cancer tissues of women colon patients[J]. Maternal and Child Health Care of China, 2014, 1: 141-143.
[5] 董欢, 林燕苹, 应学翔. 乳腺癌组织中uPA和PA-1的表达及其临床意义[J]. 肿瘤, 2013, 4: 361-367. DONG Huan, LIN Yanping, YING Xuexiang. The expressions of uPA and PA-1 in patients with breast cancer and their clinical significance[J]. Tumor, 2013, 4: 361-367.
[6] 丁萍萍, 李强. 溶血磷脂酸促卵巢癌细胞增殖机制的研究[J]. 山东大学学报(医学版), 2011, 49(7): 35-39. DING Pingping, LI Qiang. Study on mechanism of lysophosphatidic acid on proliferation of ovarian cancer cell proliferation[J]. Journal of Shandong University(Health Sciences), 2011, 49(7): 35-39.
[7] 张玉阳, 叶文蔚, 韩义香, 等. 尿激酶型纤溶酶原激活物( uPA)及其抑制物-1( PAI-1)在子宫内膜癌中的表达及其临床病理意义[J]. 中国妇幼保健, 2012, 27(18): 2824-2826. ZHANG Yuyang, YE Wenwei, HAN Yixiang, et al. Expressions of urinary plasminogen activator(uPA)and its inhibitor-1(PAI-1)in endometrial cancer and their clinicopathological significances[J]. Maternal and Child Health Care of China, 2012, 27(18): 2824-2826.
[8] Andress SA, Edwards AB, Wittliff JL. Expression of urokinase-type plasminogen activator(uPA), its receptor(uPAR), and inhibitor(PAI-1)in human breast carcinomas and their clinical relevance[J]. J Clin Lab Anal, 2012, 26(2): 93-103.
[9] Ding Y, Zhang H, Zhong M, et al. Clinical significance of the uPA system in gastric cancer with peritoneal metastasis[J]. Eur J Med Res, 2013, 18(1): 28. doi: 10.1186/2047-783X-18-28.
[10] 张晶, 王春妮, 戚美, 等. 二烯丙三硫对乳腺癌MDA-MB-231细胞增殖和侵袭的抑制及对uPA系统的调节[J]. 山东大学学报(医学版), 2012, 50(10): 61-66. ZHANG Jing, WANG Chunni, QI Mei, et al. Dially1 trisulfide inhibits proliferation and invasion of breast cancer MDA-MB-231 cells and its role in regulation of Upa system[J]. Journal of Shandong University(Health Sciences), 2012, 50(10): 61-66.
[11] 肖秀英, 于宝. PI3K/Akt信号传导通路及其在结直肠癌中的研究进展[J]. 临床肿瘤学杂志, 2011, 16(6): 558-561. XIAO Xiuying, YU Bao, PI3K/Akt singnling pathway and its advances in colorectal cancer[J]. Chinese Clinical Oncology, 2011, 16(6): 558-561.
[12] 曹亿, 郭正辉. 前列腺癌发病机制中信号传导通路的研究进展[J]. 临床泌尿外科杂志, 2011, 26(8): 632-636. CAO Yi, GUO Zhenghui. Signal transduction pathway in the pathogenesis of prostate cancer research progress[J]. Journal of Clinical Urology, 2011, 26(8): 632-636.
[13] 周建斌, 盛顺良, 周寿红, 等. 外源性硫化氢通过PI3K/Akt信号通路诱导人卵巢癌细胞凋亡[J]. 中国妇幼保健, 2013, 28(30): 5029-5032. ZHOU Jianbin, SHENG Shunliang, ZHOU Shouhong, et al. Exogenous hydrogen sulfide promotes the apoptosis through PI3K/Akt pathway in human ovarian carcinoma cells[J]. 2013, 28(30): 5029-5032.
[14] Chou RH, Hsieh SC, Yu YL, et al. Fisetin inhibits migration and invasion of human cervical cancer cells by down-regulating urokinase plasminogen activator expression through suppressing the p38 MAPK-dependent NF-κB signaling pathway[J]. PLoS One, 2013, 8(8): e71983. doi: 10.1371/journal.pone.0071983. Print 2013.
[15] Wang R, Li ZQ, Han X, et al. Integrin β3 and its ligand regulate the expression of uPA through p38MAPK in breast cancer[J]. APMIS, 2010, 118(12): 909-917.
[16] 仇会会, 叶丽平, 温有锋, 等. IL-6对卵巢癌细胞bc-l2、cyclinD1和VEGF表达的影响[J]. 山东大学学报(医学版), 2014, 52(6): 17-21. QIU Huihui, YE Liping, WEN Youfeng, et al. Effects of IL-6 on the expressions of bcl-2, cyclinD1 and VEGF in ovarian cancer cells[J]. Journal of Shandong University(Health Sciences), 2014, 52(6): 17-21.
[1] ZHOU Jing, CHANG Xiaotian, ZHOU Ting, CUI Yingying, ZHANG Bei, RONG Fengnian. Effects of PADI4 silence on ovarian cancer cell line OVCAR3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 48-53.
[2] ZHOU Jing, ZHENG Yabing, YAN Li, CHANG Xiaotian, ZHAO Shan, RONG Fengnian. Effects of estrogen and cis-platinum on PADI4 expression and cell proliferation in ovarian cancer cell line A2780 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 30-34.
[3] JIA Zong-yang, ZHANG Xiang-ning, JIN Yan-hui, WEI Mei-ling. Effects of PD98059 combined with cisplatin derivative on human ovarian carcinoma cell SKOV3 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(2): 27-32.
[4] SUN Ying1, DING Huan1, LI Xiao-qing2, LI Li1. Growth-inhibitory effect of over-expressed INPP4B in MDA-MB-231 cells via lentivirus transfection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(12): 41-45.
[5] ZHAO Ying， YAN Lei， ZHANG Hui， YU Peng， LI Ming-jiang， ZHAO Xing-bo. Expression of SPAG9 in patients with serous epithelial ovarian tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(2): 98-.
[6] JIANG Yang, ZHANG Xia, WANG Xiaoyan, LIU Fengming, SONG Xingguo, ZHANG Li ning. Gene expression in the human ovarian cancer cell line after transfection with PDCD4 [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(1): 48-.
[7] XU Hui1, ZHANG Ping1, WU Xuezhong2, ZHANG Airong1. MCP-1 gene expression in ovarian epithelial tumors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(1): 94-.
[8] LI Qi-rong,LIU Pei-shu,ZHANG Yan. Aberrant methylation of the RASSF1A gene in tissues and serums of ovarian cancer patients and its clinical significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 1046-1049.
[9] ZHU Bin,LIU Pei-shu,NING Hui,ZHOU Li-guang. [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2006, 44(10): 1040-1044.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd